IP Library Granted Patent US 7,553,491
Granted Patent B2
US 7,553,491 · App. 11/415,536 · Granted Jun 30, 2009

BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof

Assignee: University of South Florida
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,491
App. No.
11/415,536
Granted
Jun 30, 2009
Kind
B2
Abstract

The subject invention provides polynucleotide sequences, designated BIVM, and transcriptional/translational products obtained from the polynucleotide sequences of the invention. The subject invention also provides polynucleotide and polypeptide sequences provided by SEQ ID NOs:1-28. Also provided are methods of detecting the presence of BIVM nucleic acids or polypeptides in samples suspected of containing BIVM genes, BIVM transcriptional products, or BIVM translational products. These methods are also useful for the detection of BIVM orthologs. Other embodiments provide polypeptide and/or nucleic acid vaccines for the induction of an immune response to in an individual. Kits for detecting the presence of BIVM genes, orthologs thereof, BIVM polypeptides, or BIVM transcriptional products are also provided.

Claims (9)

1. An isolated polynucleotide comprising SEQ ID NO: 14 or a polynucleotide sequence fully complementary thereto.

2. The isolated polynucleotide according to claim 1 , further comprising a promoter operably linked to said polynucleotide.

3. The isolated polynucleotide according to claim 1 , further comprising a detectable label.

4. The isolated polynucleotide according to claim 1 , further comprising a heterologous polynucleotide sequence encoding a heterologous polypeptide sequence.

5. A vector comprising SEQ ID NO: 14.

6. A transformed host cell comprising a polynucleotide sequence comprising SEQ ID NO: 14.

7. The transformed host cell according to claim 6 , wherein said host cell is selected from the group consisting of Gram negative bacterial cells, Gram positive bacterial cells, yeast cells, animal cells, plant cells, and insect cells.

8. A method of producing a polypeptide comprising culturing a transformed host cell comprising SEQ ID NO: 14 under conditions that allow for the expression of the polypeptide.

9. The method according to claim 8 , further comprising the step of isolating or recovering the polypeptide.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 11, 2023
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 063610/0379 →
CONFIRMATORY LICENSE Recorded Jun 30, 2008
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021174/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2006
From: LITMAN, GARY W.; HAWKE, NOEL A.; YODER, JEFFREY A.; EASON, DONNA D.
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 017810/0573 →
Continuity (3)
Division 1041747600 · Apr 16, 2003
Provisional Application 6037314600 · Apr 16, 2002
Related Publication 20060205689A1 · Sep 14, 2006